Effect of asenapine on manic and depressive symptoms in bipolar I patients with mixed episodes: Results from post hoc analyses

This publication has 16 references indexed in Scilit:

• Attenuation of chronic mild stress-induced ‘anhedonia’ by asenapine is not associated with a ‘hedonic’ profile in intracranial self-stimulation
  Journal of Psychopharmacology, 2010
• Asenapine versus olanzapine in acute mania: a double‐blind extension study
  Bipolar Disorders, 2009
• A 3‐week, randomized, placebo‐controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states
  Bipolar Disorders, 2009
• Mixed states vs. pure mania in the french sample of the EMBLEM study: results at baseline and 24 months – European mania in bipolar longitudinal evaluation of medication
  BMC Psychiatry, 2009
• Evidence-based guidelines for treating bipolar disorder: revised second edition—recommendations from the British Association for Psychopharmacology
  Journal of Psychopharmacology, 2009
• Clinical and psychometric characterization of depression in mixed mania: A report from the French National Cohort of 1090 manic patients
  Journal of Affective Disorders, 2006
• Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians
  Bipolar Disorders, 2005
• Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression
  Neuropharmacology, 2005
• Contributions of 5-HT2C receptors to multiple actions of central serotonin systems
  European Journal of Pharmacology, 2004
• Acute Dysphoric Mania: Treatment Response to Olanzapine Versus Placebo
  Journal of Clinical Psychopharmacology, 2003